KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $35.2 billion.

  • Eli Lilly's Total Current Liabilities rose 2414.72% to $35.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $35.2 billion, marking a year-over-year increase of 2414.72%. This contributed to the annual value of $35.2 billion for FY2025, which is 2414.72% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Total Current Liabilities is $35.2 billion, which was up 2414.72% from $40.1 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Total Current Liabilities ranged from a high of $40.1 billion in Q3 2025 and a low of $11.7 billion during Q1 2021
  • Over the past 5 years, Eli Lilly's median Total Current Liabilities value was $18.8 billion (recorded in 2023), while the average stood at $22.2 billion.
  • In the last 5 years, Eli Lilly's Total Current Liabilities plummeted by 710.54% in 2021 and then surged by 6268.44% in 2025.
  • Over the past 5 years, Eli Lilly's Total Current Liabilities (Quarter) stood at $15.1 billion in 2021, then grew by 13.85% to $17.1 billion in 2022, then surged by 59.25% to $27.3 billion in 2023, then rose by 3.97% to $28.4 billion in 2024, then increased by 24.15% to $35.2 billion in 2025.
  • Its Total Current Liabilities stands at $35.2 billion for Q4 2025, versus $40.1 billion for Q3 2025 and $39.0 billion for Q2 2025.